Cancer Vaccines Headed For Mainstream
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
No longer the odd cousins of traditional pharmaceutical applications, a host of therapeutic cancer vaccines is working through late-stage trials with real, life-extending data already reported and the potential to create a lot of action in the oncology sector.